MODELING THE COST-EFFECTIVENESS OF USTEKINUMAB FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN US

被引：1
|
作者：
Verma, S. [1 ]
Dharmarajan, S. [1 ]
Yang, Y. [1 ]
机构：
[1] Univ Mississippi, University, MS 38677 USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72715-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A147 / A147
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF APREMILAST IN MODERATE TO SEVERE PSORIASIS IN SCOTLAND
    Mughal, F.
    Cawston, H.
    Kinahan, D.
    Morris, J.
    Tencer, T.
    Zhang, F.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A420 - A420
  • [22] Cost-effectiveness of apremilast in moderate to severe psoriasis in the UK
    Mughal, Farhan
    Barker, Jonathan
    Cawston, Helene
    Damera, Vidya
    Bewley, Anthony
    Morris, James
    Shaw, Tim
    Tencer, Tom
    Zhang, Frank
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB243 - AB243
  • [23] Cost-effectiveness of treatment for moderate-to-severe psoriasis
    Hankin, CS
    Feldman, SR
    Pearce, D
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 654 - 654
  • [24] COST-EFFECTIVENESS OF BIOLOGIC TREATMENTS FOR MODERATE TO SEVERE PSORIASIS
    Carretero, G.
    Moreno, J. C.
    Notario, J.
    Silvestre, J. F.
    Lopez-Belmonte, J. L.
    Gimenez, E.
    Sabater, F. J.
    Fonseca, E.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A457 - A457
  • [25] COST-EFFECTIVENESS ANALYSIS OF USTEKINUMAB COMPA RED WITH ETANERCEPT FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN COSTA RICA
    Obando, C. A.
    Desanvicente-Celis, Z.
    Herrera, J. A.
    Moreira, M.
    De Castro, J.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A607 - A607
  • [26] Cost-effectiveness of apremilast in moderate-to-severe chronic plaque psoriasis: a model analysis in the UK
    Mughal, F.
    Barker, J.
    Cawston, H.
    Damera, V.
    Bewley, A.
    Morris, J.
    Shaw, T.
    Tencer, T.
    Zhang, F.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 : 74 - 74
  • [27] Cost-effectiveness of ustekinumab in moderate to severe Crohn's disease in Sweden
    Hansson-Hedblom, Amanda
    Almond, Chrissy
    Borgstrom, Fredrik
    Sly, Indeg
    Enkusson, Dana
    Buchholt, Anders Troelsgaard
    Karlsson, Linda
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2018, 16
  • [28] Cost-effectiveness of ustekinumab in moderate to severe Crohn’s disease in Sweden
    Amanda Hansson-Hedblom
    Chrissy Almond
    Fredrik Borgström
    Indeg Sly
    Dana Enkusson
    Anders Troelsgaard Buchholt
    Linda Karlsson
    [J]. Cost Effectiveness and Resource Allocation, 16
  • [29] Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
    Reginald Villacorta
    Joel W. Hay
    Andrew Messali
    [J]. PharmacoEconomics, 2013, 31 : 823 - 839
  • [30] Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
    Villacorta, Reginald
    Hay, Joel W.
    Messali, Andrew
    [J]. PHARMACOECONOMICS, 2013, 31 (09) : 823 - 839
12345